Glyco Mira, LLC says the company received a “SBIR Phase I grant for the development of a treatment for rosacea.” According to Pascoe this may be an “anti-cathelicidin treatment.” We may hear more later this year.

In a related matter, Richard Gallo of cathelicidin fame, has applied for a patent on some rosacea method of treatment below along with the  Regents of UCSD:

Patent application title: METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS

Inventors: Richard L. Gallo Jurgen Schauber Kenshi Yamasaki
Agents: Joseph R. Baker, APC;Gavrilovich, Dodd & Lindsey LLP
Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Origin: SAN DIEGO, CA US
IPC8 Class: AA61K4800FI
USPC Class: 514 44 A
Patent application number: 20090318534
Read more